KIMBERLY RIEMER: Open Payments
NPI 1902915630 · BOULDER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 34 payments from 16 companies in 2025. Trend: 2023 $1,263 · 2024 $2,076 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $196 |
| Alnylam Pharmaceuticals Inc. | 6 | $188 |
| Edwards Lifesciences Corporation | 1 | $126 |
| Amgen Inc. | 3 | $91 |
| Esperion Therapeutics, Inc. | 5 | $88 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| PFIZER INC. | 2 | $41 |
| HEARTFLOW, INC. | 2 | $31 |
| Novo Nordisk Inc | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $28 |
Products named: JARDIANCE, AMVUTTRA, REPATHA, NEXLETOL, LEQVIO, VYNDAQEL, FFRct, Wegovy.
Industry payments across CO — which companies pay providers there.
